Compounded Medication Considerations Because the Ivm Health GLP-1 ID program uses compounded formulations that have not undergone FDA review, patients should be aware that: The safety profile may differ from FDA-approved formulations Quality control processes vary by compounding pharmacy Concentration accuracy may have more variability than pre-filled pens Long-term safety data specific to compounded formulations is limited Frequently Asked Questions Is Ivm Health a licensed telehealth platform
Tirzepatide is the active ingredient in Mounjaro and Zepbound Tirzepatide vs Semaglutide: Greater weight loss with tirzepatide as seen in clinical trials: 21.1% average weight reduction with tirzepatide 10-15% average weight reduction with semaglutide Less side effects reported with tirzepatide Less risk of hypoglycemia with tirzepatide How it works: Targets areas in the brain that suppresses appetite and reduces cravings Delays digestion and stomach emptying leaving you feeling fuller for a longer period of time, more satisfied with smaller meals and smaller portions leading to weight loss With it's combined positive benefits to blood pressure, cholesterol, and blood sugar, Tirzepatide positively impacts your cardiovascular health and decreases your risk for heart disease.
By reducing the sugar and sodium in the blood, they lower blood pressure, the pressure on the heart, and decrease stress on the kidneys, which slows down the progression of kidney disease
Many patients were oblivious to the potential side effects and often overlooked mentioning their medication use, assuming it irrelevant to their gastroenterology consultations
Several mechanisms could theoretically contribute to altered skin sensation or sensitivity during semaglutide therapy, though these remain speculative without robust clinical evidence
